Skip to main content
. 2017 Apr 6;8(33):54304–54319. doi: 10.18632/oncotarget.16876

Table 6. Detection of genes related to COX-2-Wnt/β-catenin pathway by PCR (X±S).

Group GSK3β AKT VEGF COX2 β-catenin
Control 1.00±0.10 1.00±0.08 1.00±0.10 1.00±0.08 1.00±0.06
PGE2 2.50±0.06 3.05±0.11 3.00±0.10 3.04±0.07 3.09±0.06
PGE2+TF(L) 2.35±0.02Δ 2.04±0.08Δ* 2.10±0.11Δ* 2.06±0.07Δ* 2.02±0.09Δ*
PGE2+TF(M) 2.06±0.05Δ* 1.03±0.08** 0.98±0.05Δ** 0.99±0.05** 0.96±0.10**
PGE2+TF(H) 1.50±0.06Δ** 0.63±0.04Δ** 0.72±0.07ΔΔ** 0.76±0.10Δ** 0.76±0.11Δ**
PGE2+AH6809 1.21±0.09 0.85±0.04 1.15±0.08 1.05±0.09 1.08±0.09
PGE2+Butaprost 3.05±0.08 3.61±0.09 4.14±0.10 4.05±0.02 3.54±0.04
PGE2+Butaprost+TF(H) 2.00±0.10## 2.59±0.06## 2.46±0.11## 2.42±0.11## 0.99±0.11##

Compared with PGE2 group: * P<0.05; Compared with PGE2 group: **P<0.01

Compared with PGE2+AH6809 group: ΔP<0.05; Compared with PGE2+AH6809 group: ΔΔP<0.01

Compared with PGE2+Butaprost group: #P<0.05; Compared with PGE2+Butaprost group: ##P<0.01